Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Kennedy-Wilson Holdings
KW
$1.23B
| $4.25M | ﹤0.01% |
292,668
+6,900
| +2% | +$100K |
|
|
WWE
1277
DELISTED
World Wrestling Entertainment
WWE
| $4.25M | ﹤0.01% |
105,000
+1,800
| +2% | +$72.8K |
|
|
ARNC
1278
DELISTED
Arconic Corporation
ARNC
| $4.24M | ﹤0.01% |
222,400
+5,000
| +2% | +$95.3K |
|
1279
Assured Guaranty
AGO
$3.93B
| $4.23M | ﹤0.01% |
197,000
-9,500
| -5% | -$204K |
|
|
MANT
1280
DELISTED
Mantech International Corp
MANT
| $4.23M | ﹤0.01% |
61,387
+1,100
| +2% | +$75.8K |
|
|
DCPH
1281
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.22M | ﹤0.01% |
82,300
+3,600
| +5% | +$185K |
|
|
AQUA
1282
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $4.22M | ﹤0.01% |
198,800
+3,600
| +2% | +$76.4K |
|
1283
Openlane
KAR
$3.11B
| $4.22M | ﹤0.01% |
292,900
+5,300
| +2% | +$76.3K |
|
|
EPAY
1284
DELISTED
Bottomline Technologies Inc
EPAY
| $4.2M | ﹤0.01% |
99,600
+1,400
| +1% | +$59K |
|
1285
Sanmina
SANM
$6.25B
| $4.18M | ﹤0.01% |
154,600
-3,100
| -2% | -$83.9K |
|
1286
Trinity Industries
TRN
$2.29B
| $4.17M | ﹤0.01% |
213,800
| – | – |
|
1287
Veracyte
VCYT
$2.45B
| $4.17M | ﹤0.01% |
128,200
+22,800
| +22% | +$741K |
|
1288
Inovio Pharmaceuticals
INO
$134M
| $4.16M | ﹤0.01% |
29,858
+2,716
| +10% | +$378K |
|
1289
Rogers Corp
ROG
$1.49B
| $4.15M | ﹤0.01% |
42,300
+700
| +2% | +$68.6K |
|
|
FLOW
1290
DELISTED
SPX FLOW, Inc.
FLOW
| $4.14M | ﹤0.01% |
96,618
+1,600
| +2% | +$68.5K |
|
1291
Prestige Consumer Healthcare
PBH
$3.14B
| $4.13M | ﹤0.01% |
113,500
+1,300
| +1% | +$47.4K |
|
|
ITCI
1292
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.13M | ﹤0.01% |
161,100
+27,000
| +20% | +$693K |
|
1293
Apellis Pharmaceuticals
APLS
$3.19B
| $4.13M | ﹤0.01% |
136,900
+2,300
| +2% | +$69.4K |
|
1294
eHealth
EHTH
$123M
| $4.12M | ﹤0.01% |
52,200
+5,800
| +13% | +$458K |
|
|
CUB
1295
DELISTED
Cubic Corporation
CUB
| $4.12M | ﹤0.01% |
70,900
+1,000
| +1% | +$58.2K |
|
1296
PRA Group
PRAA
$664M
| $4.12M | ﹤0.01% |
103,200
+1,800
| +2% | +$71.9K |
|
1297
Appian
APPN
$2.27B
| $4.11M | ﹤0.01% |
63,400
+1,700
| +3% | +$110K |
|
1298
CryoPort
CYRX
$446M
| $4.1M | ﹤0.01% |
86,400
+6,400
| +8% | +$303K |
|
1299
CarGurus
CARG
$3.59B
| $4.09M | ﹤0.01% |
189,000
+4,200
| +2% | +$90.8K |
|
1300
IAMGOLD
IAG
$6.44B
| $4.08M | ﹤0.01% |
1,069,200
+16,400
| +2% | +$62.6K |
|